FuelCell Energy, Inc. filed a Form 8-K with the SEC on September 2, 2026, announcing its financial results and providing a business update as of and for the three and nine months ended July 31, 2026.
C-IV AM Takes The LinkLoan ServicingRole
Universe Pharmaceuticals INC (NASDAQ: UPC) is the subject of a 9.96% ownership position held by Meridian Prosperous Limited, representing 498,922 Class A ordinary shares.
Korn Ferry (NYSE: KFY) completed its acquisition of Auxey Holdco Limited on September 1, 2026, with consideration comprising approximately £473 million and $326 million in cash. The transaction also included the issuance of 3,118,628 Korn Ferry common shares to the sellers.
Tax-Free Fixed Income Fund IV for Puerto Rico Residents, Inc. lists $234,848,199.85 ($234.8 million) in positions associated with Santander Securities LLC and BofA Securities, Inc. The sameAnnual Reportidentifies common stock at $104,133,709.44 ($104.1 million).
C-IV AM will cover each relatedpari passuand subordinate promissory note, with duties spanning both special-servicing and non-special-servicing situations.
C-IV AM is responsible for servicing and administration if the applicable loan combination enters special servicing, including any related real estate owned property. While the combination remains outside special servicing, C-IV AM will process and conduct specified reviews of material actions. The applicable pooling …
Emergent BioSolutions Inc. (NYSE: EBS) will supply additional CYFENDUS doses under a BARDA contract modification valued at $24 million ($24M), supporting anthrax preparedness efforts. The award covers CYFENDUS, also known as AV7909, an anthrax vaccine procured through the Biomedical AdvancedResearch and DevelopmentAuthority. The modification …
The appointment comes ahead of Polaryx Therapeutics, Inc. (NASDAQ: PLYX)’s planned SOTERIA trial initiation in the fourth quarter of 2026, with Charlton set to lead clinical execution and advance key milestones.
OrthoPediatrics Corp. (NASDAQ: KIDS) now has Squadron Capital LLC holding 6,526,633 common shares, equal to 25.0% of the class. The position is reported under an activist Schedule 13D framework.